Newly engineered peptide shows potential as long-acting anti-HIV drug

Posted · Add Comment
scidaily-logo-rss

A newly engineered peptide called IBP-CP24 has the potential to be further developed as a long-acting anti-HIV drug that can be used alone or in combination with a broad neutralizing antibody for the treatment and prevention of HIV-1 infection, according to a new study.

This full article appears on <a href="https://www.sciencedaily.com/releases/2019/12/191205141756.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *